Oncocyte (NASDAQ: OCX) to jump 2,000% at the open - a purely nominal change

Oncocyte (NASDAQ: OCX) stock will jump 2,000% at the open OCX stock's 20x leap will be a purely nominal price change - the real price change came yesterday with a 10% fall on the announcement that this would happen. This is just another example of our common point around here - we must be careful to distinguish between nominal price changes and real. A real price change hits us in the wallet - a nominal price change is just that the numbers change while values don't.

As to what's done at Oncocyte: “OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung” and so on. The sadness is that it doesn't seem to do this very well. The stock is down 76% over the past 12 months. 

They also have very low revenues (some $300k a quarter), a cash pile of perhaps $11 million and losses per quarter (ongoing, that is, without fair value adjustments) of $6 million or so.That's a situation that is going to need more capital soon enough.

Oncocyte stock price from NASDAQ

That's where the problem is of course. The performance has put the stock price into penny stock territory. But there's a fashion, a cultural idea perhaps, in the American markets. Penny stocks are not serious, might even be disreputable. Therefore you cannot stay on the main markets, NASDAQ and NYSE, as a penny stock. But the main markets are where you can raise capital - so, something must be done.

That something is simply to declare that 20 pieces of stock will become one. A 20 for one reverse stock split: “Oncocyte Corporation (Nasdaq: OCX) (the “Company”), a precision diagnostics company, announced today that the Company will implement a 1-for-20 reverse stock split of the outstanding shares of its common stock. The reverse stock split will be effective at 5:00 p.m. Pacific time on July 24, 2023,”

This doesn't change the value of the corporation, nor any individual holding. It just changes the number of shares that make up any of those. So, mechanically, the share price changes in the same ratio - up 20 times, or 2,000%.

This thus preserves the NASDAQ listing and so the ability to raise new capital. As a prediction we'd expect there to be a capital raise soon enough, enabled by this reverse stock split. To be able to raise capital is why they've done this after all.